Sfoglia per Rivista
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study
2019 J. Oldenburg, J.N. Mahlangu, W. Bujan, P. Trask, M.U. Callaghan, G. Young, E. Asikanius, F. Peyvandi, E. Santagostino, R. Kruse-Jarres, C. Negrier, C. Kessler, X. Jin, J. Windyga, M. Shima, S. von Mackensen
Effects of secondary prophylaxis started in adolescent and adult haemophiliacs
2008 A. Tagliaferri, M. Franchini, A. Coppola, G.F. Rivolta, C. Santoro, G. Rossetti, G. Feola, E. Zanon, A. Dragani, P. Iannaccaro, P. Radossi, P.M. Mannucci
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate : results from an Italian prospective observational study in patients with von Willebrand disease
2013 G. Castaman, A. Coppola, E. Zanon, E. Boeri, M. Musso, S. Siragusa, A.B. Federici, G. Mancuso, G. Barillari, C. Biasoli, G. Feola, M. Franchini, S. Moratelli, G. Gamba, P. Schinco, L. Valdrè, A. Dragani, G. Mazzucconi, A. Tagliaferri, M. Morfini
Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
2017 A. Srivastava, M. Serban, S. Werner, B.A. Schwartz, C.M. Kessler, S. Alkindi, S.J. Apte, G. Castaman, J.C. Gill, A. Hellmann, K. Kavakli, P.A. Kouides, P. Kuriakose, T. Lissitchkov, M. Alice, J. Mahlangu, M. Morfini, E.J. Neufeld, F. Peyvandi, M. Reding, N.I. Rodriguez, C. Ross, L. Rusen, A. Shapiro, V. Uscatescu, J. Windyga, B. Zulfikar
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency
2020 C. Djambas Khayat, S. Lohade, F. D'Souza, L.G. Shamanur, O.R. Zekavat, I. Kruzhkova, B. Schwartz, C. Solomon, S. Knaub, F. Peyvandi
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease : results of an Italian cohort study on 120 patients characterized by bleeding severity score
2010 A.B. Federici, G. Barillari, E. Zanon, M.G. Mazzucconi, R. Musso, R. Targhetta, P.M. Mannucci
Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran
2012 M. Karimi, A. Vafafar, S. Haghpanah, M. Payandeh, P. Eshghi, H. Hoofar, A. Afrasiabi, J. Gerdabi, R. Ardeshiri, M. Menegatti, F. Peyvandi
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency
2016 S.K. Austin, K. Kavakli, M. Norton, F. Peyvandi, A. Shapiro
Emerging and re-emerging infections at the turn of the millennium
2010 A.R. Zanetti, A. Zappa
Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome
2008 P. Collins, U. Budde, J.H. Rand, A.B. Federici, C.M. Kessler
European principles of haemophilia care
2008 B. T. Colvin, J. Astermark, K. Fischer, A. Gringeri, R. Lassila, W. Schramm, A. Thomas, J. Ingerslev, Inter Disciplinary Working Group
European survey on pain management in patients with haemophilia
2010 K. Holstein, R. Klamroth, R. Perez, M. Richards, A. Gringeri
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
2020 F. Stufano, L. Baronciani, P. Bucciarelli, M. Boscarino, P. Colpani, M.T. Pagliari, F. Peyvandi
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A
2019 C. Novembrino, M. Boscolo Anzoletti, M.E. Mancuso, S. Shinohara, F. Payvandi
Evaluation of an automated platelet-based assay of ristocetin cofactor activity
2011 A.S. Lawrie, I.J. Mackie, S.J. Machin, F. Peyvandi
Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease
2008 L. Baronciani, A.B. Federici, G. Cozzi, S. La Marca, M. Punzo, V. Rubini, M.T. Canciani, P.M. Mannucci
Factor VIII products and inhibitor development : the SIPPET study (survey of inhibitors in plasma-product exposed toddlers)
2007 P.M. Mannucci, A. Gringeri, F. Peyvandi, E. Santagostino
Factors influencing illness representations and perceived adherence in haemophilic patients : a pilot study
2015 G. Lamiani, I. Strada, M.E. Mancuso, A. Coppola, E. Vegni, E.A. Moja
Fifth Åland Island conference on von Willebrand disease
2018 E. Berntorp, A. Agren, L. Aledort, M. Blomback, M.H. Cnossen, S.E. Croteau, M. von Depka, A.B. Federici, A. Goodeve, J. Goudemand, P.M. Mannucci, M. Mourik, P.T. Onundarson, F. Rodeghiero, T. Szanto, J. Windyga
First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries
2018 G.F. Pierce, A. Haffar, G. Ampartzidis, F. Payvandi, S. Diop, M. El-Ekiaby, H.M. van den Berg
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile